Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06181994 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Study acronym: MESH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2026 → Dec 2026
See other at-risk trials from Montefiore Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 2026 to Dec 2026 Show 5 more changesShow less
    • Trial sites expanded: 19 → 22 locations
    • Trial arms changed: 0 → 3
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 11 of 17 entries
    • Study description expanded, about 216 words
  2. Primary and study completion dates: Dec 2025 to Aug 2026
    • Study sites: 1 to 19
    v3
  3. Primary and study completion dates: Dec 2024 to Dec 2025
    • Collaborators expanded, about 73 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
Trial Details
NCT Number NCT06181994
Lead Sponsor Montefiore Medical Center
Collaborators: Geisinger Clinic, Heidelberg University, Henri Mondor University Hospital, Ospedale Policlinico San Martino, Ospedale San Raffaele, Lehigh Valley Hospital, Mayo Clinic, Medical University of South Carolina, New York University, Oregon Health and Science University, Sisters of Mercy University Hospital, Unity Health Toronto, Sutter Health, University of Iowa, Thomas Jefferson University, University Health Network, Toronto, University Hospital, Bordeaux, University of Alabama at Birmingham, University of South Florida, University of Washington, Cornell University, Westchester Medical Center
Conditions
(from sponsor)		 Chronic Subdural Hematoma
Related terms Hematoma, Subdural, Chronic
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov